Sernova Biotherapeutics (TSX:SVA) EBIT per Share : C$-0.09 (TTM As of Jan. 2025)

View and export this data going back to 1998. Start your Free Trial

What is Sernova Biotherapeutics EBIT per Share?

Sernova Biotherapeutics's EBIT per Share for the three months ended in Jan. 2025 was C$-0.02. Its EBIT per Share for the trailing twelve months (TTM) ended in Jan. 2025 was C$-0.09.

During the past 3 years, the average EBIT per Share Growth Rate was -54.40% per year. During the past 5 years, the average EBIT per Share Growth Rate was -46.90% per year. During the past 10 years, the average EBIT per Share Growth Rate was -21.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Sernova Biotherapeutics's EBIT per Share or its related term are showing as below:

TSX:SVA' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -119.4 Med: 1.15 Max: 44.8
Current: -54.4

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Sernova Biotherapeutics was 44.80% per year. The lowest was -119.40% per year. And the median was 1.15% per year.

TSX:SVA's 3-Year EBIT Growth Rate is ranked worse than
92.66% of 1226 companies
in the Biotechnology industry
Industry Median: 5.95 vs TSX:SVA: -54.40

Sernova Biotherapeutics's EBIT for the three months ended in Jan. 2025 was C$-5.45 Mil.

Sernova Biotherapeutics EBIT per Share Historical Data

The historical data trend for Sernova Biotherapeutics's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sernova Biotherapeutics EBIT per Share Chart

Sernova Biotherapeutics Annual Data

Trend

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Oct24

EBIT per Share

Get a 7-Day Free Trial

-0.03

-0.09

-0.13

-0.10

Sernova Biotherapeutics Quarterly Data
	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
EBIT per Share	Get a 7-Day Free Trial															-0.03	-0.03	-0.02	-0.02	-0.02

Sernova Biotherapeutics EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Sernova Biotherapeutics's EBIT per Share for the fiscal year that ended in Oct. 2024 is calculated as

	EBIT per Share		(A: Oct. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-31.598	/	306.954
=	-0.10

Sernova Biotherapeutics's EBIT per Share for the quarter that ended in Jan. 2025 is calculated as

	EBIT per Share		(Q: Jan. 2025 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-5.454	/	327.475
=	-0.02

EBIT per Share for the trailing twelve months (TTM) ended in Jan. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.09

Sernova Biotherapeutics (TSX:SVA) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Sernova Biotherapeutics EBIT per Share Related Terms

Thank you for viewing the detailed overview of Sernova Biotherapeutics's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Sernova Biotherapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sernova Biotherapeutics Inc (TSX:SVA) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

SEOVF:USA PSH0:Germany PSH0:Germany PSH0:Germany

Address

700 Collip Circle, Suite 114, London, ON, CAN, N6G 4X8

Website

https://www.sernova.com

Sernova Biotherapeutics Inc is a clinical-stage company developing regenerative medicines. The company develops Cell Pouch with human donor cells or stem cells to create a biohybrid organ. The Cell Pouch is a implantable medical device designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells, which then release proteins, hormones, or other factors into the bloodstream for the long-term treatment of multiple chronic diseases such as type 1 diabetes, hypothyroid disease, and rare diseases such as hemophilia A.

Executives